Question: considering 21 CFR 56.111, what additional measures IRB should consider so that people participating in clinical trials has included details of their previous side affects
considering 21 CFR 56.111, what additional measures IRB should consider so that people participating in clinical trials has included details of their previous side affects and are not affected in future ?
Step by Step Solution
There are 3 Steps involved in it
1 Expert Approved Answer
Step: 1 Unlock
Question Has Been Solved by an Expert!
Get step-by-step solutions from verified subject matter experts
Step: 2 Unlock
Step: 3 Unlock
